340B 360
340B 360
Podcast Description
340B 360°, a new podcast from 340B Report, is your exclusive window into the industry leaders that provide products and services to hospitals, community health centers and other 340B providers to help them implement and comply with the 340B drug pricing program. Each episode, posted monthly, provides a special opportunity to get to know the C-suite executives of 340B Report’s impressive group of sponsors, the valuable expertise they provide, and their insights on key developments in this critically important drug discount program.
Podcast Insights
Content Themes
The podcast focuses on key themes such as compliance challenges, leadership in the healthcare industry, and innovations within the 340B program. For example, the first episode discusses adapting to 340B changes with Verity Solutions' CEO, covering topics like contract pharmacy restrictions and the importance of transparency in showcasing how 340B savings are utilized to enhance patient care. Other episodes may address topics like revenue generation and efficiency in healthcare technology.
340B Leaders Upfront, formerly 340B 360°, is your exclusive window into the industry leaders that provide products and services to hospitals, community health centers and other 340B providers to help them implement and comply with the 340B drug pricing program. Each episode, posted monthly, provides a special opportunity to get to know the C-suite executives of 340B Report’s impressive group of sponsors, the valuable expertise they provide, and their insights on key developments in this critically important drug discount program.
In the latest episode of our business-focused podcast 340B Leaders Upfront, host Anna Mangum sits down with two executive leaders at VytlOne: Joel Wright, President of Pharmacy Services and John Stephens, Senior Vice President of Transformation and Analytics. VytlOne is a comprehensive pharmacy services company that also offers pharmacy benefit management (PBM) services.
Key Topics Covered:
Pathways to 340B
Joel and John describe their respective pathways to 340B and to VytlOne. Joel outlines prior roles in pharmacy, including at Walgreens. John outlines his background in business development, strategy and innovation, including a stint at the specialty pharmacy service company AllianceRx that provided services to 340B providers.
Rebate Pilot
John discusses the recently paused rebate pilot program, and how covered entities are navigating the temporary injunction imposed by a federal court and the uncertainty around the pilot’s potential return. Joel encourages providers to prepare for the eventual return of the program, including thoroughly understanding cash flow impacts and reporting requirements.
Medicare Price Negotiation Program
Joel discusses the new Medicare price negotiation program and compares its implementation which began on January 1, with the paused rebate pilot. He describes the major differences in how each of these was approached, noting the short runway for covered entities (CEs) to prepare for the rebate pilot in contrast to the Medicare price negotiation program.
Drug Manufacturer Price Reductions
John outlines how price reductions negotiated by Medicare may impact 340B ceiling prices and the potential implications of this interplay for CE cash flow.
340B Pharmacy Management + PBM
Joel provides an overview of VytlOne’s unique portfolio which includes both 340B pharmacy management services as well as a PBM offering.
Follow our Podcasts
Stay tuned for more episodes of 340B Leaders Upfront, which are posted monthly! Subscribe to 340B Leaders Upfront on your favorite podcast platform or YouTube.
Bonus: Listen to Inside 340B Report, our twice-monthly podcast, to get a behind-the-scenes window into the latest 340B news and developments from the journalists at 340B Report.
Special Offer for New 340B Report Subscribers
First-time subscribers to 340B Report can use code PODCAST25 for 25% off when subscribing. Or contact us for a free 15-day trial to see why 340B Report is the indispensable source for 340B news and intelligence.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.